Skip to main content
. 2021 Aug 18;16(8):e0256271. doi: 10.1371/journal.pone.0256271

Fig 3. Tornado diagram showing one-way sensitivity analysis results for Bakri-UBT versus condom-UBT comparison.

Fig 3

As clinical effectiveness of Bakri-UBT increases, Bakri-UBT is still not cost-effective (Bakri-UBT is more expensive, more effective) at the willingness to pay threshold of INR 24,211. As effectiveness of Bakri-UBT decreases (masked), Bakri-UBT is not cost-effective (Bakri-UBT is more expensive, less effective) as compared to condom-UBT. Similarly, for condom-UBT clinical effectiveness parameter, as condom-UBT effectiveness increases, Bakri-UBT is not cost-effective (Bakri-UBT is more expensive, less effective) as compared to condom-UBT. As condom-UBT effectiveness decreases, Bakri-UBT is still not cost-effective (Bakri-UBT is more expensive, more effective) at the given WTP threshold.